Health and Healthcare

Friday's Top Biotech & Medical Stocks

From BioHealth Investor

Biotechnology

NEOPHARM INC [NEOL] +29.21%
CERAGENIX PHARMACUTL [CGXP.OB] +11.11%
AURIGA LABORATORIES [ARGA.OB] +10.34%
POLYMEDIX INC [PYMX.OB] +7.69%
PANACOS PHARMA INC [PANC] +7.28%

Diagnostic Substances

ASPENBIO PHARMA INC [APNB.OB] +11.78%
GENELABS TECH INC [GNLB] +7.98%
EPIX PHARMACEUTICALS [EPIX] +6.79%
AMER BIO MEDICA [ABMC] +6.56%
ORCHID CELLMARK INC [ORCH] +5.93%

Drug Delivery

DELCATH SYSTEMS INC [DCTH] +3.90%
NOVADEL PHARMA INC [NVD] +2.04%
QUIGLEY CORP THE [QGLY] +1.99%
BIOVAIL CORP [BVF] +1.80%
IOMED INC [IOX] +1.08%

Drug Manufacturers

EXEGENICS INC [EXEG.OB] +19.71%
TELIK INC [TELK] +14.26%
CORTEX PHARM INC [COR] +13.41%
DEPOMED INC [DEPO] +9.92%
NITROMED, INC. [NTMD] +4.90%

Medical Appliances & Equipment

CHAD THERAPEUTICS [CTU] +15.00%
IVIVI TECHNOLOGIES, [II] +12.80%
ASPECT MEDICAL SYS [ASPM] +9.20%
LANGER INC [GAIT] +8.56%
VIASYS HEALTHCARE [VAS] +6.43%

Medical Instruments & Supplies

ALPHATEC HOLDINGS [ATEC] +26.90%
BIOFORCE NANOSCIENCE [BFNH.OB] +11.69%
OCULUS INNOVATIVE SC [OCLS] +8.11%
ARISTOTLE CP [ARTL] +8.03%
MICROMED CARDIOVASCU [MMCV.OB] +7.14%

Medical Laboratories & Research

SPHERIX INC [SPEX] +3.14%
AETERNA ZENTARIS [AEZS] +1.94%
ERESEARCHTECHNOLOG [ERES] +1.79%
ENZO BIOCHEM INC [ENZ] +1.25%
NATL DENTEX CP [NADX] +0.52%

http://www.biohealthinvestor.com/

Take This Retirement Quiz To Get Matched With A Financial Advisor (Sponsored)

Take the quiz below to get matched with a financial advisor today.

Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests.

Here’s how it works:
1. Answer SmartAsset advisor match quiz
2. Review your pre-screened matches at your leisure. Check out the advisors’ profiles.
3. Speak with advisors at no cost to you. Have an introductory call on the phone or introduction in person and choose whom to work with in the future

Take the retirement quiz right here.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.